Skip to content
Trial Eligibility
Menu

Graded Insulin Suppression Test P&F

NCT06592261

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The goal of this study is to learn about how the hormone insulin controls blood sugar in a variety of people. The main question it aims to answer is about how much insulin the body actually needs to maintain a normal blood sugar level. Participants will be asked to come in for a one-day study visit in which they will undergo a "graded insulin suppression test" ("GIST").

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Insulin Resistance
  • Hyperinsulinemia
  • Obesity
  • Healthy

Eligibility basics and study details

Study type
Interventional
Phase
Phase 1
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Columbia University
Last updated on ClinicalTrials.gov
September 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

New York · 1

  • Columbia University Irving Medical Center · New York, NY

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.